Morgan Stanley
MTEM

Morgan Stanley’s Molecular Templates, Inc. MTEM Stock Holding History

Morgan Stanley’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,201
Closed -$7.31K – 8248
2024
Q3 		$7.31K Hold
5,201
– – ﹤0.01% 6805
2024
Q2 		$5.98K Hold
5,201
– – ﹤0.01% 6809
2024
Q1 		$11.7K Sell
5,201
-5,251
-50% -$17.7K ﹤0.01% 6657
2023
Q4 		$39K Buy
10,452
+5,226
+100% +$27.3K ﹤0.01% 6453
2023
Q3 		$33K Sell
5,226
-2
-0% -$16 ﹤0.01% 6327
2023
Q2 		$37.6K Sell
5,228
-1,934
-27% -$13.2K ﹤0.01% 6325
2023
Q1 		$40.8K Buy
7,162
+1,517
+27% +$10.2K ﹤0.01% 6355
2022
Q4 		$27.8K Sell
5,645
-1,897
-25% -$15.7K ﹤0.01% 6545
2022
Q3 		$85K Sell
7,542
-2,835
-27% -$35.6K ﹤0.01% 6165
2022
Q2 		$143K Sell
10,377
-5,180
-33% -$121K ﹤0.01% 6078
2022
Q1 		$805K Sell
15,557
-11,461
-42% -$506K ﹤0.01% 5123
2021
Q4 		$1.59M Sell
27,018
-106
-0.4% -$7.94K ﹤0.01% 4744
2021
Q3 		$2.73M Buy
27,124
+5,159
+23% +$532K ﹤0.01% 4309
2021
Q2 		$2.58M Buy
21,965
+21,584
+5,665% +$2.83M ﹤0.01% 4441
2021
Q1 		$72K Sell
381
-22,891
-98% -$4.01M ﹤0.01% 6180
2020
Q4 		$3.28M Buy
23,272
+22,813
+4,970% +$3.37M ﹤0.01% 3721
2020
Q3 		$75K Sell
459
-10,365
-96% -$1.84M ﹤0.01% 5555
2020
Q2 		$2.24M Buy
10,824
+10,493
+3,170% +$2.44M ﹤0.01% 3495
2020
Q1 		$66K Sell
331
-1,962
-86% -$430K ﹤0.01% 5359
2019
Q4 		$481K Buy
2,293
+1,648
+256% +$237K ﹤0.01% 4941
2019
Q3 		$63K Buy
645
+351
+119% +$32.7K ﹤0.01% 5621
2019
Q2 		$36K Sell
294
-142
-33% -$15.4K ﹤0.01% 5735
2019
Q1 		$38K Sell
436
-1,078
-71% -$79K ﹤0.01% 5787
2018
Q4 		$92K Sell
1,514
-115
-7% -$8.02K ﹤0.01% 5585
2018
Q3 		$132K Sell
1,629
-92
-5% -$7.05K ﹤0.01% 5611
2018
Q2 		$135K Buy
1,721
+256
+17% +$29K ﹤0.01% 5665
2018
Q1 		$176K Buy
1,465
+966
+194% +$145K ﹤0.01% 5521
2017
Q4 		$75K Buy
499
+169
+51% +$21.2K ﹤0.01% 5727
2017
Q3 		$34K Buy
330
+16
+5% +$1.38K ﹤0.01% 5891
2017
Q2 		$20K Hold
314
– – ﹤0.01% 6090
2017
Q1 		$29K Sell
314
-133
-30% -$12.4K ﹤0.01% 5980
2016
Q4 		$33K Buy
447
+335
+299% +$25.6K ﹤0.01% 5863
2016
Q3 		$12K Sell
112
-21
-16% -$2.88K ﹤0.01% 6076
2016
Q2 		$13K Sell
133
-213
-62% -$15.2K ﹤0.01% 5991
2016
Q1 		$26K Sell
346
-1,125
-76% -$66.4K ﹤0.01% 5842
2015
Q4 		$116K Sell
1,471
-2,657
-64% -$1.31M ﹤0.01% 5328
2015
Q3 		$2.77M Buy
4,128
+3,527
+587% +$2.51M ﹤0.01% 3197
2015
Q2 		$400K Buy
601
+452
+303% +$299K ﹤0.01% 4865
2015
Q1 		$100K Sell
149
-1,955
-93% -$1.29M ﹤0.01% 5528
2014
Q4 		$1.1M Sell
2,104
-1,363
-39% -$682K ﹤0.01% 4078
2014
Q3 		$2.06M Buy
3,467
+786
+29% +$544K ﹤0.01% 3399
2014
Q2 		$1.75M Buy
2,681
+526
+24% +$348K ﹤0.01% 3593
2014
Q1 		$1.69M Sell
2,155
-483
-18% -$392K ﹤0.01% 3566
2013
Q4 		$2.03M Buy
2,638
+2,430
+1,168% +$1.83M ﹤0.01% 3368
2013
Q3 		$161K Sell
208
-1,214
-85% -$998K ﹤0.01% 4971
2013
Q2 		$1.23M Buy
+1,422
New +$1.2M ﹤0.01% 3547

Other funds holding MTEM

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Morgan Stanley's MTEM Position: Q4 2024 in Review

Morgan Stanley sold out of Molecular Templates, Inc. (MTEM) in Q4 2024, closing a stake of 5,201 shares — an estimated $7.31K sold.

Morgan Stanley first reported a position in MTEM in Q2 2013 and held it in 46 quarters. The position peaked at $3.28M in Q4 2020. 3 funds tracked by Wall St. Rank hold MTEM as of Q4 2024.

  • Morgan Stanley reported no remaining Molecular Templates, Inc. position as of Q4 2024 after selling out during the quarter.
  • Morgan Stanley sold 5,201 Molecular Templates, Inc. shares in Q4 2024, an estimated $7.31K.
  • Morgan Stanley first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 46 quarters.
  • Morgan Stanley's Molecular Templates, Inc. position peaked at $3.28M in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2024.

Based on Morgan Stanley's 13F filing for Q4 2024, filed 14 Feb 2025.